Alopecia Treatment Market Investigation Highlighting Grow
The Alopecia Treatment Market 2021 – 2027 report covers the important factors driving the growth of the market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the market and other insights across various key segments.
Alopecia is a condition associated with excessive hair loss or hair damage. Treatment of alopecia plays a key role in modern healthcare, since it aids hair fall prevention and hair regrowth. Unhealthy lifestyle, hormonal imbalance and ageing, are certain the factors causing condition of alopecia.
The global alopecia treatment market size accounted for US$ 7,325.0 million in 2017 and is projected to witness a 4.9% CAGR over the forecast period (2018–2026).
Rising product approvals and launches, along with robust pipelines are expected to drive the global market growth
Rising launches of products along with robust pipelines are expected to propel the global alopecia treatment market over the forecast period. For instance, Fidia Pharma, in November 2018, launched in Italy, Trinov hair growth lotion for growth of hair. Furthermore, Eli Lilly and Company, in September 2018, began clinical trial of phase 2 to assess efficacy and the safety of the drug Baricitinib to treat alopecia areata patients. This study is projected to be over by August 2022.
Increasing initiatives including crowdfunding campaigns along with rising collaborations by market companies is expected to boost the growth of the global alopecia treatment market over the forecast period. For instance, the U.K.-based firm developing restoration therapies cellular hair-HairClone, in 2018, launched its campaign for public crowdfunding, in collaboration with Capital Cell, a company of crowdfunding. Similarly, RepliCel Life Sciences Inc. and Shiseido Company, Limited, in May 2013, declared technology development transfer framework agreement and collaboration for RepliCel’s technology of hair regeneration – RCH-01.
Increasing Alopecia Areata’ prevalence and high focus on development research within North America are expected to boost the growth of the market.
North America region holds the largest share in the global alopecia treatment market, due to rising prevalence of Alopecia Areata and activities of research by market companies. For instance, in 2017, as per the National Alopecia Areata Foundation (NAAF), alopecia areata troubles over 6.8 Mn individuals in the U.S. with 2.1% lifetime risk. Furthermore, the NAAF is focusing on broadening efforts of research through 2 committees, such as the Clinical Research Advisory Council (CRAC) and the Basic Research Advisory Council (BRAC), to develop the Alopecia Areata Treatment Development Program
Rising strategies of acquisition in this region by market companies are key factors expected to drive the growth of the global alopecia treatment market. For instance, Aclaris Therapeutics, Inc., in August 2017, acquired Confluence Life Sciences, Inc. that expanded the immunology and inflammation pipeline of Aclaris with the inclusion of the lead product candidate of Confluence, CDD-450, IL2-inducible T-cell kinase inhibitor, and topical Janus kinase inhibitors.
Furthermore, market players collaborating with regulation authorities along with other governmental organizations is expected to further drive the global North America alopecia treatment market growth during the forecast period. For instance Helomics, Precision Therapeutics Inc., and the National Alopecia Areata Foundation (NAAF), in April, 2019, entered in an agreement for treating people suffering from autoimmune skin disease known as alopecia areata. This agreement was aimed at providing a next-generation patient registry for driving research on novel treatments to people having this disease.
Major Key Players Include In Alopecia Treatment Market: Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Merck & Co., Inc., Daiichi Sankyo Company, Limited, and Sun Pharmaceutical Industries Ltd.
Main points in Alopecia Treatment Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Alopecia Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Alopecia Treatment Industry Impact
Chapter 2 Global Alopecia Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Alopecia Treatment (Volume and Value) by Type
2.3 Global Alopecia Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Alopecia Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Alopecia Treatment Market Analysis
Chapter 6 East Asia Alopecia Treatment Market Analysis
Chapter 7 Europe Alopecia Treatment Market Analysis
Chapter 8 South Asia Alopecia Treatment Market Analysis
Chapter 9 Southeast Asia Alopecia Treatment Market Analysis
Chapter 10 Middle East Alopecia Treatment Market Analysis
Chapter 11 Africa Alopecia Treatment Market Analysis
Chapter 12 Oceania Alopecia Treatment Market Analysis
Chapter 13 South America Alopecia Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Alopecia Treatment Business
Chapter 15 Global Alopecia Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Alopecia Treatment Market Investigation Highlighting Grow
- CYRx MD Announces New Hair Care Product Line
- Experimental method might help cancer patients keep their hair
- Potential of Hairstylists and Barbers to Identify Disorders of Hair Loss
- Painless Hair Transplants
- Hairline International Offers Free Pick up and Drop for Customers Till Mar 31, 2015
- New technique may reveal the health of human hair follicles
- New Salons Hair Loss Treatments
- Selenium Sulfide Market Size
- Newly Released Peer-Reviewed Publication Further Validates RepliCels Use of Dermal Sheath Cup Cells to Treat Pattern Baldness
- 46 Million Women Across the US Affected By Hair Loss